J Burghouts

1.2k total citations
38 papers, 890 citations indexed

About

J Burghouts is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Burghouts has authored 38 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Burghouts's work include Lung Cancer Research Studies (9 papers), Cancer therapeutics and mechanisms (7 papers) and Acute Myeloid Leukemia Research (6 papers). J Burghouts is often cited by papers focused on Lung Cancer Research Studies (9 papers), Cancer therapeutics and mechanisms (7 papers) and Acute Myeloid Leukemia Research (6 papers). J Burghouts collaborates with scholars based in Netherlands, Belgium and Italy. J Burghouts's co-authors include Pieter E. Postmus, Giuseppe Giaccone, A. Kirkpatrick, Nico van Zandwijk, Otilia Dalesio, Henk H. Berendsen, Andrea Ardizzoni, Bonne Biesma, C. Debruyne and Vivianne C. G. Tjan‐Heijnen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

J Burghouts

36 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Burghouts Netherlands 16 678 366 286 242 88 38 890
Anna Efremidis Greece 21 602 0.9× 156 0.4× 180 0.6× 420 1.7× 76 0.9× 59 1.0k
C.G. Alexopoulos Greece 15 421 0.6× 118 0.3× 148 0.5× 219 0.9× 123 1.4× 34 789
Terrence Moore United States 8 434 0.6× 181 0.5× 148 0.5× 241 1.0× 252 2.9× 12 903
R. Jackson Forcier United States 11 427 0.6× 149 0.4× 207 0.7× 133 0.5× 67 0.8× 18 785
William B. Fisher United States 17 760 1.1× 160 0.4× 212 0.7× 846 3.5× 58 0.7× 39 1.2k
Yutaka Horie Japan 17 255 0.4× 237 0.6× 310 1.1× 121 0.5× 204 2.3× 59 976
Hoo G. Chun United States 15 440 0.6× 70 0.2× 304 1.1× 210 0.9× 154 1.8× 31 821
J.M. Tourani France 15 481 0.7× 94 0.3× 152 0.5× 183 0.8× 80 0.9× 34 807
Jiajia Zhang United States 16 867 1.3× 140 0.4× 250 0.9× 319 1.3× 111 1.3× 57 1.2k
Meredith K. Chuk United States 14 429 0.6× 105 0.3× 175 0.6× 260 1.1× 57 0.6× 29 858

Countries citing papers authored by J Burghouts

Since Specialization
Citations

This map shows the geographic impact of J Burghouts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Burghouts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Burghouts more than expected).

Fields of papers citing papers by J Burghouts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Burghouts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Burghouts. The network helps show where J Burghouts may publish in the future.

Co-authorship network of co-authors of J Burghouts

This figure shows the co-authorship network connecting the top 25 collaborators of J Burghouts. A scholar is included among the top collaborators of J Burghouts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Burghouts. J Burghouts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tjan‐Heijnen, Vivianne C. G., Sue Caleo, Pieter E. Postmus, et al.. (2003). Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923). Annals of Oncology. 14(2). 248–257. 19 indexed citations
2.
Ardizzoni, Andrea, Vivianne C. G. Tjan‐Heijnen, Pieter E. Postmus, et al.. (2002). Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923. Journal of Clinical Oncology. 20(19). 3947–3955. 75 indexed citations
3.
Tjan‐Heijnen, Vivianne C. G., Pieter E. Postmus, Andrea Ardizzoni, et al.. (2001). Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study. Annals of Oncology. 12(10). 1359–1368. 79 indexed citations
4.
Mauriac, L., Corinne Veyret, J. Wildiers, et al.. (1998). Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881. Ghent University Academic Bibliography (Ghent University). 8 indexed citations
5.
Wit, Ronald de, Henk van den Berg, J Burghouts, et al.. (1998). Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles. British Journal of Cancer. 77(9). 1487–1491. 39 indexed citations
6.
7.
8.
Giaccone, Giuseppe, Otilia Dalesio, Gordon McVie, et al.. (1993). Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.. Journal of Clinical Oncology. 11(7). 1230–1240. 108 indexed citations
9.
Postmus, Pieter E., et al.. (1993). Long term survival of small cell lung cancer patients after chemotherapy. British Journal of Cancer. 67(4). 822–824. 16 indexed citations
10.
11.
Graaf, Winette T.A. van der, Hanny Haaxma-Reiche, J Burghouts, & Pieter E. Postmus. (1993). Teniposide for meningeal carcinomatosis of small cell lung cancer. Lung Cancer. 10(3-4). 247–249. 5 indexed citations
12.
Wagener, D. J. Th., J. Wils, J Burghouts, et al.. (1993). Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer. Annals of Oncology. 4(5). 426–428. 8 indexed citations
13.
Punt, Cornelis J.A., P.H.M. de Mulder, J Burghouts, & D. J. Th. Wagener. (1992). Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study. Cancer Chemotherapy and Pharmacology. 29(4). 326–328. 7 indexed citations
14.
Tellingen, Olaf van, et al.. (1992). Bio-analysis of vinorelbine by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 573(2). 328–332. 26 indexed citations
15.
Wagener, D. J. Theo, et al.. (1991). Phase II trial of cisplatin for adenocarcinoma of unknown primary site. European Journal of Cancer and Clinical Oncology. 27(6). 755–757. 11 indexed citations
16.
Postmus, Pieter E., A. Kirkpatrick, Otilia Dalesio, et al.. (1988). Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial. Cancer Treatment Reviews. 15. 41–44. 8 indexed citations
17.
Willemze, R., Ulrich Jäger, U. Jehn, et al.. (1988). Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC leukemia cooperative group phase II study. European Journal of Cancer and Clinical Oncology. 24(11). 1721–1725. 19 indexed citations
18.
Postmus, Pieter E., et al.. (1987). Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy. European Journal of Cancer and Clinical Oncology. 23(9). 1409–1411. 120 indexed citations
19.
Wagener, D. J. Th., et al.. (1985). Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 15(1). 86–87. 34 indexed citations
20.
Burghouts, J, et al.. (1980). Improved method of enrichment for immature myeloid cells from normal human bone marrow.. PubMed. 8(5). 515–20. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Efremidis Breakdown of academic impact, for papers by C.G. Alexopoulos Breakdown of academic impact, for papers by Terrence Moore Breakdown of academic impact, for papers by R. Jackson Forcier Breakdown of academic impact, for papers by William B. Fisher Breakdown of academic impact, for papers by Yutaka Horie Breakdown of academic impact, for papers by Hoo G. Chun Breakdown of academic impact, for papers by J.M. Tourani Breakdown of academic impact, for papers by Jiajia Zhang Breakdown of academic impact, for papers by Meredith K. Chuk
Rankless by CCL
2026